Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Uterine Cervical Dysplasia 2Triple Negative Breast Neoplasms 2Head and Neck Neoplasms 2Vulvar Neoplasms 1Vulvar Diseases 1Prostatic Neoplasms 1Papillomavirus Infections 1Neoplasms 1Neoplasm Metastasis 1Mouth Neoplasms 1Carcinoma in Situ 1Carcinoma 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Cisplatin 7Cetuximab 6Radiotherapy, Intensity-Modulated 4pembrolizumab 3durvalumab 3Radiotherapy 2Radiation 2Observation 2Drug Therapy 2Celecoxib 2Bupropion 2130-nm albumin-bound paclitaxel 2trametinib 1sodium thiosulfate 1gluconic acid 1ficlatuzumab 1Zinc 1Watchful Waiting 1Varenicline 1Transcutaneous Electric Nerve Stimulation 1Tobacco Use Cessation Devices 1Tadalafil 1Sirolimus 1RRx-001 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Pilocarpine 1Photochemotherapy 1Periodontal Debridement 1Oral Hygiene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Mouth Neoplasms × Indomethacin × Clear all
NCT00210470 2020-12-11

A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer

Brooklyn ImmunoTherapeutics, LLC

Phase 2 Completed
27 enrolled 16 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡